WordNet

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 急性腎同種移植片拒絶反応：治療 acute renal allograft rejection treatment
2. 急性心臓同種移植拒絶反応：治療 acute cardiac allograft rejection treatment
3. 再生不良性貧血：予後および治療 aplastic anemia prognosis and treatment
4. 後天性赤芽球癆 acquired pure red cell aplasia
5. 急性移植片対宿主病の治療：臨床試験 treatment of acute graft versus host disease clinical trials

Characterization of in vitro antimurine thymocyte globulin-induced regulatory T cells that inhibit graft-versus-host disease in vivo.

Ruzek MC, Waire JS, Hopkins D, Lacorcia G, Sullivan J, Roberts BL, Richards SM, Nahill SR, Williams JM, Scaria A, Dzuris J, Shankara S, Garman RD.SourceImmunology and Clinical Laboratory Sciences, Biologics R&D, Framingham, MA, USA. melanie.ruzek@genzyme.com
Blood.Blood.2008 Feb 1;111(3):1726-34. Epub 2007 Nov 19.
Antithymocyte/antilymphocyte globulins are polyclonal antihuman T-cell antibodies used clinically to treat acute transplant rejection. These reagents deplete T cells, but a rabbit antihuman thymocyte globulin has also been shown to induce regulatory T cells in vitro. To examine whether antithymocyte
PMID 18025149

[Therapeutic effect of antithymocyte/antilymphocyte globulin on severe aplastic anemia and therapy-related complications].

Yu F, Tang SQ, Wang JW.SourceDepartment of Pediatrics, General Hospital of People's Liberation Army, Beijing 100853, China.
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics.Zhongguo Dang Dai Er Ke Za Zhi.2006 Dec;8(6):479-81.
OBJECTIVE: Immunsuppressive therapy is a major therapy for severe aplastic anemia, and antithymocyte /antilymphocyte globulin (ATG/ALG) is usually used. This study investigated the therapeutic effect of ATG/ALG on severe aplastic anemia and explored the management of therapy-related complications.ME
PMID 17178040

Immunosuppressive Treatment of Acquired Aplastic Anemia and Immune-Mediated Bone Marrow Failure Syndromes

Favourable response to antithymocyte or antilymphocyte globulin in low-risk myelodysplastic syndrome patients with a 'non-clonal' pattern of X-chromosome inactivation in bone marrow cells